Scope of the Study
Ibuprofen is a non steroidal anti-inflammatory drug (NSAIDs) used as a painkiller as well as for treating fever and inflammation. This medication can be available to take without doctor's prescriptions. It also pain and inflammation caused by conditions that effect joints, bones, and muscles. In addition to this, Ibuprofen also reduces migraine, toothache and others. It was initially developed in 1960 while researching for a safer alternative for aspirin.
The market study is being classified by Type (USP and EP) and major geographies with country level break-up.
Xinhua Pharmaceutical (China), IOLCP (India), Granules Biocause (China), Strides Pharma Science Limited. (India), BASF (Germany), SI Group, Inc. (United States), Xinhua-Perrigo Pharmaceutical (China), Hisoar (China), Unipex (France) and Rochem (United States) are some of the key players profiled in the study. Additionally, the Vendors which are also part of the research are Aasraw Biochemical Technology Co.ltd (China), Biotechnica Pharma Global (BPG) (Algeria), DEAFARMA (Italy), Mallinckrodt Pharmaceuticals (United States), Nishchem International Pvt. Ltd. (NIPL) (India) and Teligent, Inc. (United States).
Very seldom Ibuprofen manufacturers are available in the global market. Thus, the overall competition is on lower side.. But, some Stringent Government Regulation might pose an entry barriers. The overall medicinal market will have slight Oligopoly among the key manufacturers. Research Analyst at AMA predicts that Chinese Vendors will contribute to the maximum growth of Global Ibuprofen Sales market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Ibuprofen Sales market by Type, Application and Region.
On the basis of geography, the market of Ibuprofen Sales has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). United States region held largest market share in the year 2018. If we see Market by Form, the sub-segment i.e. Tablet will boost the Ibuprofen Sales market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Process, the sub-segment i.e. Intravenous will boost the Ibuprofen Sales market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Adoption of Painkillers in Acute Pain Conditions
- Improving interdependence on Analgesic Medication in case of IV Ibuprofen
- Huge demand in the market with Minimum Competition
- Adoption of Ibuprofens with minimized cardiovascular side effects
- Introduction to Ibuprofen Gel
- Posses Number of Side Effects including Nausea, Upsets Stomach, Vomiting, Headache, Diarrhea
- This medication can increase the patient's blood pressure
- Pose some serious threats to Kidney
- Demand for Ibuprofen is the most as compared to its productivity
- Opportunities in untapped markets where the government subsidies can assist in upsurging demand
On 9th August, 2018, SI Group Inc. has announced that it will be increasing its capacity for ibuprofen manufacture by 25%, to be completed by 2020.
"The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has said that patients taking ibuprofen at doses of 2,400 mg or more per day are at a higher risk of heart attack or stroke than those taking lower doses." and "Practs Committee has stated that the level of risk will not increase when taking up to 1,200 mg of ibuprofen, which is typically the highest recommended dose for OTC versions."
Key Target Audience
Ibuprofen Manufacturers, Ibuprofen Distributors Traders, Government and Private Health Care Organisations, Hospitals, Medical Institutes and Others
Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase